Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Bond

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Women'S Health (London, England)|August 6, 2014
'Uncommon' variants linked to risk of ovarian cancerTheo Bond
Biomarkers in Medicine|May 14, 2013
Melanoma resistance gene identifiedTheo Bond
Regenerative Medicine|April 23, 2014
STAP cells: stress-induced stem cells?Theo Bond
Pharmacogenomics|February 19, 2014
Third clinical trial reinforces the use of the GeneSight® pharmacogenomic testTheo Bond
Biomarkers in Medicine|May 14, 2013
Identification of chemosensitive pancreatic cancer with gene profilingTheo Bond
Women'S Health (London, England)|June 24, 2014
New targeted cancer therapy for resistant gynecologic cancersTheo Bond
Expert Review of Clinical Pharmacology|April 19, 2013
US FDA approves three new drugs for Type 2 diabetesTheo Bond
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Women'S Health (London, England)|August 6, 2014
'Uncommon' variants linked to risk of ovarian cancerTheo Bond
Biomarkers in Medicine|May 14, 2013
Melanoma resistance gene identifiedTheo Bond
Regenerative Medicine|April 23, 2014
STAP cells: stress-induced stem cells?Theo Bond
Pharmacogenomics|February 19, 2014
Third clinical trial reinforces the use of the GeneSight® pharmacogenomic testTheo Bond
Biomarkers in Medicine|May 14, 2013
Identification of chemosensitive pancreatic cancer with gene profilingTheo Bond
Women'S Health (London, England)|June 24, 2014
New targeted cancer therapy for resistant gynecologic cancersTheo Bond
Expert Review of Clinical Pharmacology|April 19, 2013
US FDA approves three new drugs for Type 2 diabetesTheo Bond
Pageof 1